Who owns Copaxone?
Copaxone is owned by Teva (Israel, NYSE: TEVA).[1]
Evidence: Teva Pharmaceutical Industries Limited Annual Report on Form 10-K filed 2026-02-03, SEC EDGAR, 3 February 2026. Verified from filings; last checked .
Key facts
- Current owner
- Teva Pharmaceutical Industries Limited verified
- Owner HQ
- 🇮🇱 Israel, Tel Aviv
- Origin
- 🇮🇱 Israel
- Category
- Healthcare & pharma › Drug makers › Pharmaceuticals
- Parent ticker
- NYSE: TEVA
- Last verified
- · 1 sources
About Copaxone
Copaxone (glatiramer acetate injection) is Teva's long-established treatment for relapsing forms of multiple sclerosis, used in the United States and Europe. Teva says its share declined through 2025 as generic glatiramer and newer oral therapies took patients, and it remains in litigation against generic makers in several European countries over the product.
Ownership timeline of Copaxone
Where Copaxone sits in Teva
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Teva ownership tree →
See the full Teva brand portfolio (4) →
Other brands owned by Teva
Teva controls 4 brands on Brandtree, 4 of them in healthcare & pharma.
Also in healthcare & pharma
Other brands in pharmaceuticals, and who owns them
Teva has more brands in pharmaceuticals on Brandtree than any other owner: 4 of 13.
About the owner: Teva
Teva is a publicly listed company headquartered in Tel Aviv, Israel. Brandtree records 4 brands under its control, and it is listed as NYSE: TEVA.
Teva is an Israeli-domiciled pharmaceutical company that sells generic medicines worldwide alongside a growing list of branded innovative drugs. Its 2025 annual report puts the weight of its strategy on four products: AUSTEDO for movement disorders, AJOVY for migraine, UZEDY for schizophrenia and bipolar disorder, and COPAXONE for multiple sclerosis. Its United States operations are run from Parsippany, New Jersey.
🇮🇱 Copaxone and other Israeli brands
Brandtree records a controlling owner for 52 brands that began in Israel. 3 of them (6%) are now controlled by a company headquartered in another country; Copaxone is not one of them.
- Achla — Strauss Group 🇮🇱
- Base44 — Wix 🇮🇱
- Be — Shufersal 🇮🇱
- Bingo Blitz — Playtika 🇮🇱
- Caesarstone — Caesarstone 🇮🇱
- Challenge Airlines IL — Challenge Group 🇮🇱
Frequently asked questions
Who is the parent company of Copaxone?
The parent company of Copaxone is Teva, a publicly listed company headquartered in Israel.
Is Copaxone Israeli?
Yes. Copaxone originated in Israel and its owner, Teva, is also headquartered in Israel.
Is Copaxone still owned by Teva?
Yes. As of 10 October 2026, Copaxone is still owned by Teva. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Teva Pharmaceutical Industries Limited Annual Report on Form 10-K filed 2026-02-03 — SEC EDGAR, SEC Form 10-K, published 3 February 2026; retrieved 10 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.